430 related articles for article (PubMed ID: 16272307)
1. Prostaglandin D2 causes preferential induction of proinflammatory Th2 cytokine production through an action on chemoattractant receptor-like molecule expressed on Th2 cells.
Xue L; Gyles SL; Wettey FR; Gazi L; Townsend E; Hunter MG; Pettipher R
J Immunol; 2005 Nov; 175(10):6531-6. PubMed ID: 16272307
[TBL] [Abstract][Full Text] [Related]
2. Differential modulation of human basophil functions through prostaglandin D2 receptors DP and chemoattractant receptor-homologous molecule expressed on Th2 cells/DP2.
Yoshimura-Uchiyama C; Iikura M; Yamaguchi M; Nagase H; Ishii A; Matsushima K; Yamamoto K; Shichijo M; Bacon KB; Hirai K
Clin Exp Allergy; 2004 Aug; 34(8):1283-90. PubMed ID: 15298571
[TBL] [Abstract][Full Text] [Related]
3. Delta12-prostaglandin D2 is a potent and selective CRTH2 receptor agonist and causes activation of human eosinophils and Th2 lymphocytes.
Gazi L; Gyles S; Rose J; Lees S; Allan C; Xue L; Jassal R; Speight G; Gamble V; Pettipher R
Prostaglandins Other Lipid Mediat; 2005 Jan; 75(1-4):153-67. PubMed ID: 15789622
[TBL] [Abstract][Full Text] [Related]
4. A dominant role for chemoattractant receptor-homologous molecule expressed on T helper type 2 (Th2) cells (CRTH2) in mediating chemotaxis of CRTH2+ CD4+ Th2 lymphocytes in response to mast cell supernatants.
Gyles SL; Xue L; Townsend ER; Wettey F; Pettipher R
Immunology; 2006 Nov; 119(3):362-8. PubMed ID: 17067313
[TBL] [Abstract][Full Text] [Related]
5. Novel function of CRTH2 in preventing apoptosis of human Th2 cells through activation of the phosphatidylinositol 3-kinase pathway.
Xue L; Barrow A; Pettipher R
J Immunol; 2009 Jun; 182(12):7580-6. PubMed ID: 19494281
[TBL] [Abstract][Full Text] [Related]
6. Chemoattractant receptor-homologous molecule expressed on Th2 cells activation in vivo increases blood leukocyte counts and its blockade abrogates 13,14-dihydro-15-keto-prostaglandin D2-induced eosinophilia in rats.
Shichijo M; Sugimoto H; Nagao K; Inbe H; Encinas JA; Takeshita K; Bacon KB; Gantner F
J Pharmacol Exp Ther; 2003 Nov; 307(2):518-25. PubMed ID: 12975488
[TBL] [Abstract][Full Text] [Related]
7. Synergistic effect of PGD2 via prostanoid DP receptor on TNF-alpha-induced production of MCP-1 and IL-8 in human monocytic THP-1 cells.
Hirano Y; Shichijo M; Deguchi M; Nagira M; Suzuki N; Nishitani Y; Hattori M; Arimura A
Eur J Pharmacol; 2007 Mar; 560(1):81-8. PubMed ID: 17307163
[TBL] [Abstract][Full Text] [Related]
8. Antagonism of the prostaglandin D2 receptor CRTH2 attenuates asthma pathology in mouse eosinophilic airway inflammation.
Uller L; Mathiesen JM; Alenmyr L; Korsgren M; Ulven T; Högberg T; Andersson G; Persson CG; Kostenis E
Respir Res; 2007 Feb; 8(1):16. PubMed ID: 17328802
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of interleukin-1beta-induced matrix metalloproteinases 1 and 13 production in human osteoarthritic chondrocytes by prostaglandin D2.
Zayed N; Afif H; Chabane N; Mfuna-Endam L; Benderdour M; Martel-Pelletier J; Pelletier JP; Motiani RK; Trebak M; Duval N; Fahmi H
Arthritis Rheum; 2008 Nov; 58(11):3530-40. PubMed ID: 18975308
[TBL] [Abstract][Full Text] [Related]
10. A paracrine role for chemoattractant receptor-homologous molecule expressed on T helper type 2 cells (CRTH2) in mediating chemotactic activation of CRTH2+ CD4+ T helper type 2 lymphocytes.
Vinall SL; Townsend ER; Pettipher R
Immunology; 2007 Aug; 121(4):577-84. PubMed ID: 17437532
[TBL] [Abstract][Full Text] [Related]
11. 11-Dehydro-thromboxane B2, a stable thromboxane metabolite, is a full agonist of chemoattractant receptor-homologous molecule expressed on TH2 cells (CRTH2) in human eosinophils and basophils.
Böhm E; Sturm GJ; Weiglhofer I; Sandig H; Shichijo M; McNamee A; Pease JE; Kollroser M; Peskar BA; Heinemann A
J Biol Chem; 2004 Feb; 279(9):7663-70. PubMed ID: 14668348
[TBL] [Abstract][Full Text] [Related]
12. Antagonists of the prostaglandin D2 receptor CRTH2.
Pettipher R; Hansel TT
Drug News Perspect; 2008; 21(6):317-22. PubMed ID: 18836589
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of PI3K and calcineurin suppresses chemoattractant receptor-homologous molecule expressed on Th2 cells (CRTH2)-dependent responses of Th2 lymphocytes to prostaglandin D(2).
Xue L; Gyles SL; Barrow A; Pettipher R
Biochem Pharmacol; 2007 Mar; 73(6):843-53. PubMed ID: 17196174
[TBL] [Abstract][Full Text] [Related]
14. Induction of apoptosis in non-small cell lung carcinoma A549 cells by PGD₂ metabolite, 15d-PGJ₂.
Wang JJ; Mak OT
Cell Biol Int; 2011 Nov; 35(11):1089-96. PubMed ID: 21999315
[TBL] [Abstract][Full Text] [Related]
15. Pharmacologic profile of OC000459, a potent, selective, and orally active D prostanoid receptor 2 antagonist that inhibits mast cell-dependent activation of T helper 2 lymphocytes and eosinophils.
Pettipher R; Vinall SL; Xue L; Speight G; Townsend ER; Gazi L; Whelan CJ; Armer RE; Payton MA; Hunter MG
J Pharmacol Exp Ther; 2012 Feb; 340(2):473-82. PubMed ID: 22106101
[TBL] [Abstract][Full Text] [Related]
16. Targeting the PGD
Kupczyk M; Kuna P
Drugs; 2017 Aug; 77(12):1281-1294. PubMed ID: 28612233
[TBL] [Abstract][Full Text] [Related]
17. CRTH2-specific binding characteristics of [3H]ramatroban and its effects on PGD2-, 15-deoxy-Delta12, 14-PGJ2- and indomethacin-induced agonist responses.
Sugimoto H; Shichijo M; Okano M; Bacon KB
Eur J Pharmacol; 2005 Nov; 524(1-3):30-7. PubMed ID: 16256979
[TBL] [Abstract][Full Text] [Related]
18. Cutting edge: chemoattractant receptor-homologous molecule expressed on Th2 cells plays a restricting role on IL-5 production and eosinophil recruitment.
Chevalier E; Stock J; Fisher T; Dupont M; Fric M; Fargeau H; Leport M; Soler S; Fabien S; Pruniaux MP; Fink M; Bertrand CP; McNeish J; Li B
J Immunol; 2005 Aug; 175(4):2056-60. PubMed ID: 16081770
[TBL] [Abstract][Full Text] [Related]
19. Prostaglandin D2 selectively induces chemotaxis in T helper type 2 cells, eosinophils, and basophils via seven-transmembrane receptor CRTH2.
Hirai H; Tanaka K; Yoshie O; Ogawa K; Kenmotsu K; Takamori Y; Ichimasa M; Sugamura K; Nakamura M; Takano S; Nagata K
J Exp Med; 2001 Jan; 193(2):255-61. PubMed ID: 11208866
[TBL] [Abstract][Full Text] [Related]
20. Fevipiprant (QAW039), a Slowly Dissociating CRTh2 Antagonist with the Potential for Improved Clinical Efficacy.
Sykes DA; Bradley ME; Riddy DM; Willard E; Reilly J; Miah A; Bauer C; Watson SJ; Sandham DA; Dubois G; Charlton SJ
Mol Pharmacol; 2016 May; 89(5):593-605. PubMed ID: 26916831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
